Pages that link to "Q43791081"
Jump to navigation
Jump to search
The following pages link to Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. (Q43791081):
Displaying 50 items.
- Ether à go-go potassium channel expression in soft tissue sarcoma patients (Q21245739) (← links)
- Ca2+-activated K+ channels in human melanoma cells are up-regulated by hypoxia involving hypoxia-inducible factor-1alpha and the von Hippel-Lindau protein (Q24676422) (← links)
- Modeling Electrophysiological Coupling and Fusion between Human Mesenchymal Stem Cells and Cardiomyocytes (Q26779602) (← links)
- Voltage-gated ion channels in cancer cell proliferation (Q27010511) (← links)
- Structure of the C-terminal region of an ERG channel and functional implications (Q27678809) (← links)
- Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma (Q28069313) (← links)
- Calmodulin Regulates Human Ether à Go-Go 1 (hEAG1) Potassium Channels through Interactions of the Eag Domain with the Cyclic Nucleotide Binding Homology Domain (Q28119193) (← links)
- Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy (Q28483692) (← links)
- Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels revealed with fluorescence and electrophysiological methods (Q28591022) (← links)
- Expression of TRPC6 channels in human epithelial breast cancer cells (Q33331489) (← links)
- Positive correlation between the expression of hEag1 and HIF-1α in breast cancers: an observational study (Q33629346) (← links)
- The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors (Q33685939) (← links)
- The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia (Q33715775) (← links)
- Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle (Q33822451) (← links)
- Transcriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel (Q33927117) (← links)
- Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines (Q34099591) (← links)
- In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors. (Q34325900) (← links)
- Inhibition of hEAG1 and hERG1 potassium channels by clofilium and its tertiary analogue LY97241. (Q35044882) (← links)
- Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastastic breast cancer cell line (Q35046156) (← links)
- Overexpression of Eag1 potassium channels in clinical tumours. (Q35107467) (← links)
- Roles of K+ channels in regulating tumour cell proliferation and apoptosis (Q35719297) (← links)
- Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival (Q35830894) (← links)
- Temple-Baraitser Syndrome and Zimmermann-Laband Syndrome: one clinical entity? (Q36047304) (← links)
- Clinical relevance of ion channels for diagnosis and therapy of cancer (Q36345960) (← links)
- Cell Cycle-dependent Changes in Localization and Phosphorylation of the Plasma Membrane Kv2.1 K+ Channel Impact Endoplasmic Reticulum Membrane Contact Sites in COS-1 Cells (Q36444002) (← links)
- p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells (Q36613887) (← links)
- Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors (Q37021593) (← links)
- K+ channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis (Q37024827) (← links)
- Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis (Q37392731) (← links)
- The TREK2 Channel Is Involved in the Proliferation of 253J Cell, a Human Bladder Carcinoma Cell (Q37417632) (← links)
- Voltage-gated potassium channels as therapeutic targets (Q37464784) (← links)
- Role of membrane potential in the regulation of cell proliferation and differentiation (Q37534485) (← links)
- Zinc transporters and dysregulated channels in cancers (Q37545055) (← links)
- Ion channels as targets for cancer therapy (Q37901394) (← links)
- Membrane potential and cancer progression (Q38123808) (← links)
- The roles of K(+) channels in cancer (Q38171243) (← links)
- Potassium channels in cell cycle and cell proliferation. (Q38184978) (← links)
- Kv10.1 K(+) channel: from physiology to cancer. (Q38690062) (← links)
- Docetaxel modulates the delayed rectifier potassium current (IK) and ATP-sensitive potassium current (IKATP) in human breast cancer cells. (Q38938154) (← links)
- Eag1 Voltage-Dependent Potassium Channels: Structure, Electrophysiological Characteristics, and Function in Cancer. (Q39119019) (← links)
- KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients (Q39195311) (← links)
- Aberrant expression of Eag1 potassium channels in gastric cancer patients and cell lines (Q40079888) (← links)
- Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. (Q40625148) (← links)
- Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells (Q40651585) (← links)
- Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC. (Q41201274) (← links)
- K(+) channels and cell cycle progression in tumor cells (Q41849048) (← links)
- Mechanism of block of hEag1 K+ channels by imipramine and astemizole (Q41952692) (← links)
- Differential regulation of human Eag1 channel expression by serum and epidermal growth factor in lung and breast cancer cells (Q42208169) (← links)
- Cortactin controls surface expression of the voltage-gated potassium channel K(V)10.1. (Q42431018) (← links)
- Electrophysiological properties of human mesenchymal stem cells (Q44632042) (← links)